Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,035 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Management of Undernutrition on Discharge From Hospital by Dieticians and Physical Activity Teachers at Home

NCT06976827

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: Centre hospitalier Henri Mondor d'Aurillac Aurillac, France

View Trial Details

Not yet recruiting

The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia

NCT06849401

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma

NCT06963632

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT

NCT06963866

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: The Affiliated Hospital oh Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details

Not yet recruiting

Combining Electrical Impedance Tomography and Thoracic Ultrasound Toinvestigate Dynamic Changes

NCT06958770

Conditions: ARDS (Moderate or Severe), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

NCT06956092

Conditions: B Cell Lymphoma (BCL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: The First Affiliated Hospital of Zhengzhou University, Department of Oncology Zhengzhou, Henan, China

View Trial Details

Not yet recruiting

Zanubrutinib Combined With BR in the First-line Treatment of Waldenström's Macroglobulinemia

NCT06942507

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Not yet recruiting

Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia

NCT06830733

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Hospital Marqués de Valdecilla Santander, Cantabria, Spain

Clínica Universitaria de Navarra Madrid, Spain

Hospital 12 de Octubre Madrid, Spain

Hospital Universitario Virgen de la Arrixaca Murcia, Spain

View Trial Details

Not yet recruiting

Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)

NCT06931704

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: CHU Angers Angers, France

CH Côte Basque Bayonne, France

CHU Besançon Besançon, France

CHU Caen Caen, France

View all 36 locations

View Trial Details

Not yet recruiting

Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma

NCT06918015

Conditions: BTK Inhibitors, Follicular Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions